First, as Zhang et al. demonstrated that TIKI2 can not only cleave the canonical Wnt-Wnt3a but also cleave the non-canonical Wnts such as Wnt5a [10], TIKI2 may cleave Wnt3a to inactivate the Wnt canonical pathway in RCC. Here, TRABD2B is linked to renal cell carcinoma.